MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
Leading pharmaceutical companies including Pfizer, MEI Pharma, and Onconova Therapeutics will present breakthrough developments in kinase inhibitor research at the upcoming Boston summit in February 2023.